Virtual Exercise Program for Peripheral Neuropathy

(EX-CIPN Trial)

This trial aims to determine if a virtual exercise program, called EX-CIPN, can reduce symptoms like numbness and tingling in cancer survivors who have completed chemotherapy. Participants will either follow this exercise program or continue with their usual care, and researchers will compare their progress. The study seeks individuals who have completed chemotherapy, experience neuropathic pain, and can walk and use video calls. If successful, this program could ease daily activities for those dealing with lingering side effects from cancer treatment. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that exercise programs like EX-CIPN are generally safe for people with nerve problems caused by chemotherapy, known as CIPN. One study found that both exercise and physical therapy effectively managed CIPN symptoms without major side effects. Participants handled the programs well. Another study found that exercises, including activities for the heart, strength, and balance, offer a low-risk way to reduce CIPN symptoms.

Researchers are excited about the EX-CIPN exercise-based intervention for peripheral neuropathy because it offers a unique approach compared to current treatments, which typically include medications like gabapentin or duloxetine for symptom relief. Unlike these standard drug therapies, EX-CIPN incorporates a personalized virtual exercise program that is remotely monitored and supported by healthcare professionals. This innovative approach not only aims to improve physical function but also provides ongoing clinical support and engagement, which could enhance patient adherence and overall outcomes. By focusing on exercise and remote care, this treatment has the potential to address the condition in a more holistic and accessible manner.

Research has shown that exercise might alleviate symptoms of chemotherapy-induced peripheral neuropathy (CIPN), which involves nerve pain and numbness following cancer treatment. Some studies have found that individuals who exercised experienced less severe symptoms than those who did not. For example, an aerobic exercise program reduced CIPN symptoms in ovarian cancer patients. However, other studies did not find significant improvement, indicating the need for further research. In this trial, participants in the EX-CIPN Exercise-based Intervention arm will receive an individualized exercise program with remote monitoring and clinical support. Overall, despite mixed results, exercise appears to be a low-risk option that might help manage CIPN symptoms.⁶⁷⁸⁹¹⁰